Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
Baxter
Cerilliant
Julphar
McKinsey
Deloitte
AstraZeneca
Fuji

Generated: May 22, 2018

DrugPatentWatch Database Preview

TRIAPRIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Triaprin patents expire, and what generic alternatives are available?

Triaprin is a drug marketed by Dunhall and is included in one NDA.

The generic ingredient in TRIAPRIN is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.
Summary for TRIAPRIN
Drug patent expirations by year for TRIAPRIN
Synonyms for TRIAPRIN
624746-94-7
Acetaminophen mixture with butalbital
ACETAMINOPHEN; BUTALBITAL
Axocet
Bupap
BUTALBITAL AND ACETAMINOPHEN
Butalbital mixt. with Acetaminophen
C11H16N2O3.C8H9NO2
Cephadyn
Dolgic
DTXSID60211514
LS-178494
Repan CF
SCHEMBL4064624

US Patents and Regulatory Information for TRIAPRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dunhall TRIAPRIN acetaminophen; butalbital CAPSULE;ORAL 089268-001 Jul 2, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
UBS
Daiichi Sankyo
AstraZeneca
US Department of Justice
Cipla
Citi
Moodys
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.